Comparison of the effect of risperidone and aripiprazole in the treatment of the acute phase of mania
Phase 3
Recruiting
- Conditions
- Comparison of the effect of risperidone and aripiprazole as a clinical trial in treating the acute phase of mania in patients with bipolar disorders.
- Registration Number
- IRCT20231022059813N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Patient consent to participate in the study
Suffering from the acute phase of mania of bipolar disorder, which must be confirmed by a psychiatrist
Exclusion Criteria
History of sensitivity and allergy to aripiprazole and risperidone
Physical illness
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of risperidone and aripiprazole in the treatment of manic phase of bipolar disorder. Timepoint: The beginning of the study and 7 and 14 days after the beginning of the mania phase. Method of measurement: Jung's Mania Rating Questionnaire.
- Secondary Outcome Measures
Name Time Method